Drugs / Nilvadipine
Nilvadipine
also known as
CL 287,389 · Dl-nilvadipine · Escor · FK 235 · FR-34235 · Nilvadipino · Nivadil · Nivadip · +2 more
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02017340 Comparator | Apr 2013 → Dec 2016 | Alzheimer disease | Prof Brian Lawlor | Completed | No outcome recorded |
Evidence & citations 14 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nilvadipine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02017340 ↗ |
| Known as | CL 287,389 | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Known as | Dl-nilvadipine | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Known as | Escor | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Known as | FK 235 | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Known as | FR-34235 | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Known as | Nilvadipino | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Known as | Nivadil | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Known as | Nivadip | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Known as | Nivadipine | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Known as | SK&F 102,362 | ChEMBL registry synonym — accepted as the source's own label CHEMBL517427 ↗ |
| Action | Inhibit | “calcium channel blocker nilvadipine” PMID 32210906 ↗ Mar 2020 |
| Modality | Small molecule | “a dihydropyridine calcium channel blocker nilvadipine with anti-inflammatory properties” PMID 32210906 ↗ Mar 2020 |
| Route | Oral | “Participants took a trial treatment capsule once a day after breakfast for 78 weeks” PMID 30248105 ↗ Sep 2018 |